Authors:
Schneider, JC
Blazy, I
Dechaux, M
Rabier, D
Mason, NP
Richalet, JP
Citation: Jc. Schneider et al., Response of nitric oxide pathway to L-arginine infusion at the altitude of4,350 m, EUR RESP J, 18(2), 2001, pp. 286-292
Authors:
Pappas, PA
Saudubray, JM
Tzakis, AG
Rabier, D
Carreno, MR
Gomez-Marin, O
Huijing, F
Gelman, B
Levi, DM
Nery, JR
Kato, T
Mittal, N
Nishida, S
Thompson, JF
Ruiz, P
Citation: Pa. Pappas et al., Serum citrulline and rejection in small bowel transplantation: A preliminary report, TRANSPLANT, 72(7), 2001, pp. 1212-1216
Authors:
De Lonlay, P
Benelli, C
Fouque, F
Ganguly, A
Aral, B
Dionisi-Vici, C
Touati, G
Heinrichs, C
Rabier, D
Kamoun, P
Robert, JJ
Stanley, C
Saudubray, JM
Citation: P. De Lonlay et al., Hyperinsulinism and hyperammonemia syndrome: Report of twelve unrelated patients, PEDIAT RES, 50(3), 2001, pp. 353-357
Authors:
Baumgartner, MR
Hu, CAA
Almashanu, S
Steel, G
Obie, C
Aral, B
Rabier, D
Kamoun, P
Saudubray, JM
Valle, D
Citation: Mr. Baumgartner et al., Hyperammonemia with reduced ornithine, citrulline, arginine and proline: anew inborn error caused by a mutation in the gene encoding Delta(1)-pyrroline-5-carboxylate synthase, HUM MOL GEN, 9(19), 2000, pp. 2853-2858
Authors:
Thuillier, L
Sevin, C
Demaugre, F
Brivet, M
Rabier, D
Droin, V
Aupetit, J
Abadi, N
Kamoun, P
Saudubray, JM
Bonnefont, JP
Citation: L. Thuillier et al., Genotype/phenotype correlation in carnitine palmitoyl transferase II deficiency: lessons from a compound heterozygous patient, NEUROMUSC D, 10(3), 2000, pp. 200-205
Authors:
Saudubray, JM
De Lonlay, P
Touati, G
Martin, D
Nassogne, MC
Castelnau, P
Sevin, C
Laborde, C
Baussan, C
Brivet, M
Vassault, A
Rabier, D
Bonnefont, JP
Kamoun, P
Citation: Jm. Saudubray et al., Genetic hypoglycaemia in infancy and childhood: Pathophysiology and diagnosis, J INH MET D, 23(3), 2000, pp. 197-214
Authors:
Touati, G
Rusthoven, E
Depondt, E
Dorche, C
Duran, M
Heron, B
Rabier, D
Russo, M
Saudubray, JM
Citation: G. Touati et al., Dietary therapy in two patients with a mild form of sulphite oxidase deficiency. Evidence for clinical and biological improvement, J INH MET D, 23(1), 2000, pp. 45-53
Authors:
Parfait, B
de Lonlay, P
von Kleist-Retzow, JC
Cormier-Daire, V
Chretien, D
Rotig, A
Rabier, D
Saudubray, JM
Rustin, P
Munnich, A
Citation: B. Parfait et al., The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia, EUR J PED, 158(1), 1999, pp. 55-58
Authors:
van der Knaap, MS
Jakobs, C
Hoffmann, GF
Duran, M
Muntau, AC
Schweitzer, S
Kelley, RI
Parrot-Roulaud, F
Amiel, J
De Lonlay, P
Rabier, D
Eeg-Olofsson, O
Citation: Ms. Van Der Knaap et al., D-2-hydroxyglutaric aciduria: Further clinical delineation, J INH MET D, 22(4), 1999, pp. 404-413
Authors:
Saudubray, JM
Martin, D
de Lonlay, P
Touati, G
Poggi-Travert, F
Bonnet, D
Jouvet, P
Boutron, M
Slama, A
Vianey-Saban, C
Bonnefont, JP
Rabier, D
Kamoun, P
Brivet, M
Citation: Jm. Saudubray et al., Recognition and management of fatty acid oxidation defects: A series of 107 patients, J INH MET D, 22(4), 1999, pp. 488-502
Authors:
Bonnet, D
Martin, D
de Lonlay, P
Villain, E
Jouvet, P
Rabier, D
Brivet, M
Saudubray, JM
Citation: D. Bonnet et al., Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children, CIRCULATION, 100(22), 1999, pp. 2248-2253